Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study.
A double-blind study with tranexamic acid (Cyklokapron) was carried out in 17 patients with chronic urticaria. All patients had slightly depressed C1-chronic esterase inhibitor value. No significant differences were found between TA and placebo treatment periods.
D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D014148:Tranexamic Acid / Q000627:therapeutic use*; D014581:Urticaria / Q000188:drug therapy*
D003509:Cyclohexanecarboxylic Acids; D010919:Placebos; D014148:Tranexamic Acid